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Abstract² This paper presents some findings from a 
randomised controlled trial in patients with upper-limb 
weakness in acute stroke services within the UK¶V National 
Health Service. Three patients were selected from the robot 
arm of the trial; one who exhibited a large increase in Fugl-
Meyer score (change > 30); one who exhibited a moderate 
change (10 < change < 20) and a subject who demonstrated no 
change between baseline and follow-up. The results from robot 
assistance level and target achievement over the course of the 
treatment are presented for the three patients, demonstrating 
the system¶s ability to automatically alter the assistance level as 
patients progress. 
Keywords- robotic rehabilitation, stroke, upper limb, 
randomised control trial. 
I.  INTRODUCTION 
Stroke is the leading cause of adult disability in the UK, 
every year 152,000 people have a stroke. Of those who 
survive, approximately half experience physical disability 
with upper-limb weakness being the most common 
impairment. Upon discharge from hospital, around 37% of 
survivors will require assistance with activities of daily 
living (ADL) [1]. The average cost per patient of care and 
rehabilitation is £23,315 (34,750 USD) leading to a total 
Health and social care costs bill of approximately £4.38bn 
(6.53bn USD). This places a significant financial and 
resource burden on the NHS leading to overstretched stroke 
services. It is recognised that the most recovery occurs in 
the first few weeks following stroke, this is seen as a result 
of the combination of rehabilitation and spontaneous 
recovery, however due to limited therapy resources patients 
spend the majority of their time during this acute stage in 
their beds. This may lead to sub-optimal recovery as it is 
recognised that recovery is related to the frequency and 
quality of therapeutic intervention [2,3].    
By utilising assistive robotic systems to supplement 
conventional rehabilitation, it is possible to increase the 
intensity of therapeutic exercises patients receive without a 
significant increase in therapy resources. This is especially 
desirable in the acute stages of stroke, while patients are still 
within the hospital environment. Robotic systems are 
designed to undertake some of the repetitive movement 
tasks required for functional recovery of the arm, freeing up 
therapists to undertake more complex targeted intervention 
for which robotic systems may be unsuitable. The overall 
aim being that patients can spend more time engaged in 
therapeutic exercise than with conventional therapy alone.  
Rehabilitation robotics is a large and growing area of 
research with an ever expanding number of systems being 
developed internationally. As these systems are developed 
and in some cases commercialised, there is a growing body 
of evidence as to the efficacy of providing therapeutic 
exercise to the upper-limb via a robotic system. A review of 
upper-limb robotic stroke rehabilitation [4] cited 28 such 
robotic systems. These systems are configured in one of two 
ways; either as an end-effector based robotic arm whereby 
the patient interacts with the patient via a handle or wrist 
orthosis; or an exoskeleton system that has several contact 
points along the arm with robot joints coincidental with the 
human joints. An example of the former type is the MIT-
Manus [5]. Probably the most established and clinically 
proven upper-limb rehabilitation system, it has been 
commercialised as the InMotion ARMTM Interactive 
Therapy System.  It is a planar two DoF robotic arm system 
which can include additional attachments for the hand to 
increase functionality.  A second end-effector based system 
is the Arm-Guide [6] works on an adaptable linear slide 
mechanism.  Both systems have been assessed in 
randomised controlled trials. 
An example of an exoskeleton system is ARMin. 
ARMin [7] is a seven DoF exoskeleton robot system that 
provides task-specific exercise to people with stroke. 
Allowing three dimensional exercise, the system provides 
relatively large workspace, also incorporating a hand 
opening and closing mechanism.  
The aforementioned systems all feature in a Cochrane 
review of randomised controlled trials (RCTs) for upper-
limb robotic stroke rehabilitation [8]. It looked at the 
outcomes of 19 trials involving 666 participants. Primary 
outcomes were concerned with Activities of Daily Living 
with secondary outcomes looking at motor function (Fugl-
Meyer Assessment ± Upper Extremity) and muscle strength. 
Conclusions of the review stated that robotic systems for 
upper-limb rehabilitation are more effective that other 
interventions when considering ADLs and motor function, 
however the authors state that the changes are such that they 
may have a limited effect on the clinical meaning for the 
patient.  
A more recently published RCT [9] using the ARMin 
system recruited 77 patients who were at least six months 
post-stroke and delivered a total of 24 sessions of robot or 
conventional therapy depending on the trial arm. Their 
findings showed a minor difference between conventional 
and robotic therapy, inferring that robotic therapy could be 
more beneficial that conventional therapist delivered 
therapy however improvements in Fugl-Meyer Upper 
Extremity Assessment were still small for each group; 
3.25points (SD1.68) for robotic therapy and 2.47 points 
(SD1.67) for control arm. As highlighted above, the effects 
RI WKLV LPSURYHPHQW RQ SDWLHQW¶V clinical outcome may be 
limited.  
iPAM (intelligent Pneumatic Arm Movement) is a 
robotic system developed at the University of Leeds to 
provide assistive upper-limb exercise to a wide range of 
patients with arm weakness as a result of stroke. It combines 
the mechanical simplicity and ease of attachment of an end-
effector system with the human-joint control benefits of an 
exoskeleton system while proving a large workspace. This 
paper presents some results from a RCT undertaken with 
three iPAM MkII systems within acute stroke services in the 
UK National Health Service. The iPAM MkII system is 
introduced followed by a description of the RCT and 
summary of the experience. There then follows a small case 
study relating assistance level provided by the robots and 
the exercise target achievement when looking at three 
patients with differing outcomes.  
II. IPAM MKII 
Developed by a multidisciplinary team including 
engineers, rehabilitation physicians, therapists, stroke 
survivors and their carers, iPAM has been specifically 
designed to meet the needs of the various stakeholders, 
helping to ensure end-user acceptance. The design process 
for both the iPAM MkI and MkII can be found in [10] and 
[11] respectively. 
A. Hardware 
Mimicking the method in which a therapist provided 
assistive exercise to the human arm, the robot consists of 
two identical robot arms attached to a base unit. Each arm 
has three pneumatically-actuated revolute joints, allowing 
control of the robot end-points in Cartesian space. At the 
end of each robot arm are detachable orthoses (easily 
swappable for left and right sided operation) that allow three 
passive rotational DoF aligned with the centre of the human 
arm to ensure the arm is always comfortably aligned within 
the system. A distal orthosis attaches to the lower arm close 
to the wrist while the proximal orthosis attaches to the 
upper-arm around the mid-point between the elbow and 
shoulder. As the arm is calibrated within the system at the 
start of each session, the exact positioning of the orthoses on 
the arm is not required, making attaching the robot a quick 
process.   
Each end-effector contains a JR3 six DoF force/torque 
transducers for measuring the robot/patient interaction force 
while each robot joint contains a rotary sensor for measuring 
joint position. An air pressure sensor and patient and 
emergency stop buttons are used to ensure safe operation of 
the system. 
Low-level control is undertaken on a dedicated 
embedded controller running deterministic real-time 
software while a standard personal computer provides 
communication protocols and runs the high-level 
supervisory control and the patient and clinician interfaces 
(SILCK clinic). 
Additional hardware consists of a standard wheelchair 
with a modified back rest that allows a large range of 
movement close to the body; a docking station that holds the 
calibration tools and locates the wheelchair correctly 
relative to the robot base unit; a large LCD display that 
presents the patient interface to the user allowing the patient 
to engage with the system; and a stand-alone low-noise 
medical grade air-compressor. The iPAM MkII system can 
be seen in Figure 1. 
 
B. Control 
As the two robots are independent it is essential that they 
coordinate effectively; any misalignment of the end 
effectors could result in excessive torques being applied to 
the SDWLHQW¶V limb. As such a control strategy was developed 
that controls the robots using a six DoF model of the human 
arm. With three active DoF at each robot end-effector it is 
possible to control six DoF of the human arm, two 
translational and three rotational DoF at the shoulder, and a 
single rotational DoF at the elbow. By providing control 
through the human arm model in human task space rather 
than the robot task space it is possible to ensure safe 
 
 
Figure 1. The iPAM MkII Robotic Rehabilitation System 
coordination of the two robotic arms. Trajectories are passed 
from the high-level controller in the form of human joint 
positions and rotations, target locations and admittance 
control parameters. When exercises commence the robot 
enters a parked position moving the patients arm to a 
comfortable location close to the patients lap. The patient is 
then presented with a virtual target to which they should 
reach towards; iPAM will assist them to reach the target. 
The system utilises an admittance control scheme to 
modulate the demand position of the robots based on the 
measured human joint torques and forces. The admittance 
function modulates the input trajectory for each human DoF 
as a function of measured force/torque and takes the form: 
Gx=F /(Kx+Cx.s)     (1) 
where K and C are stiffness and damping terms 
respectively. An exponential mapping function is used for 
converting the assistance level in terms of percentage as 
seen by the physiotherapist to the stiffness term K used by 
the admittance controller. For rotary joints, 100% sets a 
joint stiffness of 40Nm/rad while 0% gives 0.075Nm/rad. 
Damping is static at 0.25Nms/rad. Translational DoF at 
shoulder maintained a high stiffness setting throughout.  The 
new demand positions for the human joints are then 
converted to robot end-effector positions using the forward 
kinematics of the human arm. The inverse kinematics of the 
robot arms are then used to calculate the desired robot joint 
angles. PID controllers are used at each robot joint to 
provide the position control. A detailed description of the 
control system has been presented previously [12]. 
C. Operation 
 A typical iPAM treatment session will last for 1 hour 
and consist of approximately 40 to 45mins of robot-assisted 
exercise although this will vary from patient to patient. At 
the beginning of a treatment session, the system initialises 
into a passive operating mode called warm standby. In this 
mode the robots are supporting their own weight such that 
they are free to move around. This is an inherent benefit of 
using pneumatic actuators, the pressure regulating valves 
are set to maintain a specific pressure, manually moving the 
robots causes the pressure on one side of the low friction 
pneumatic cylinders to increase while decreasing it on the 
other, the pressure regulating valves quickly adapt to reduce 
the higher pressure and increase the lower pressure 
balancing the pressure. This makes the whole system 
innately back-driveable. 
Patients are seated in the chair and their trunk secured 
using a four point harness. This is to prevent excessive trunk 
movement, ensuring the movement is predominantly as a 
result of arm use. A shoulder monitor consisting of three 
pull-cord potentiometers is attached to the shoulder using 
medical tape. This provides the relative movement of the 
shoulder to an initialised position which is fed into the 
inverse kinematics solver for the human arm model, 
improving accuracy. It is also used as a safety check to 
detect a change in patient posture. The orthoses are then 
attached. They use a modified blood pressure cuff that can 
gently hold the arm in place while a barrier material with a 
high-friction coating is used to ensure the orthosis does not 
slip during use.  
The next stage is to calibrDWHWKHSDWLHQW¶VDUPZLWKLQWKH
system. This is to match the human arm model used by the 
controller with the patient¶s arm. Two custom tools are used 
to take measurements, one giving the relative positon of the 
orthoses to bony markers on the limb and the second 
providing the initial shoulder offset from the robot base unit. 
Once calibrated the attending therapist or assistant 
undertakes a visual inspection of the calibrated arm model, 
matching the 3D representation of the arm shown on the 
patient interface and the real arm.  
Once calibrated the therapist must prescribe an exercise 
set for the patient to undertake. These are set through the 
high-level clinician interface (SILCK clinic). This provides 
the therapist with the mechanism for converting clinical 
assessment of the patient into robot specific information 
used to develop exercise prescriptions. Exercises sets can 
consist of fixed tasks or open tasks: 
Fixed tasks: These involve the physical recording of a 
specific arm movement trajectory by guiding the SDWLHQW¶V
arm through a specific movement while the robot records 
the trajectory in terms of human joint angles, this can then 
be replayed by the system as an exercise. A push button on 
the proximal robot handle is used to set virtual target 
locations.  
Open tasks: These involve the selection of a specific 
treatment strategy that is suitable for the particular patient. 
Depending on strategy chosen, the system will 
automatically generate movement trajectories tailored to the 
particular treatment strategy. Open tasks consist of exercises 
featuring movements between 8 separate targets. Targets 
appear on the patient interface along with the 3D 
representation of the pDWLHQW¶VOLPE)LJ).  
 
The two categories of open task exercises are: 
Category A: This strategy is suitable for patients with 
limited arm movement or high-tone at the elbow and/or 
shoulder, the strategy aims to gradually increase the range 
of movement by undertaking small reach/retrieve 
movements at either table level or at an increasing elevation. 
The controller will automatically increase the range of 
movement as the patient successfully and consistently 
 
Figure 2. Patient Interface screen appear on a large display infront of 
patient during exercise and displays human arm model and virtual targets. 
reaches the target locations. The strategy will also introduce 
lateral movements as the patient progresses. The assistance 
level (K value in admittance controller) is set manually by 
the therapist. 
Category B: This strategy is suitable for those with a 
wide range of movement deficits but is not suitable for 
patients with high tone. This strategy commences with a 
number of simple, limited range reach/retrieve exercises to 
warm-up the patient. The workspace is then separated up 
into four outer-reach quadrants and the system will 
undertake a number of movements exploring each quadrant 
in turn. All targets are placed within a safe workspace for 
the patient, physically defined by the therapist. As patients 
consistently reach targets over consecutive exercise 
attempts, the assistance level will drop at 5% intervals. The 
therapist has the choice to remove specific quadrants from 
the prescription and to manually intervene in the assistance 
setting. 
Once the appropriate exercise prescription has been 
chosen the therapist can select the desired number of 
exercise attempts and the duration of the exercise session. 
The exercise set can then commence with the patient only 
requiring indirect therapist or assistant supervision. The 
patient has a patient stop button on their unaffected side to 
halt the exercise set at any time; alerting the therapist via an 
audible and visual alarm. At the end of the session, the 
system returns to warm standby and the orthoses are quickly 
removed allowing the patient to exit the system. 
III. RANDOMISED CONTROL TRIAL  
The iPAM MkII system has successfully been used as 
part of an RCT within acute stroke services of the NHS. 
Initially iPAMs were installed in three different NHS trusts 
hospitals in Hull, Pontefract and Aberdeen. The aims of the 
RCT were to determine the feasability and practicalities of 
delivering a RCT using iPAM within NHS stroke services; 
to obtain clinical outcome data to determine appropriate 
sample sizes for future Phase 3 clinical trial design and to 
assess the safety of the system within a clinical 
environment.  
A. Trial design  
A prospective, randomised, controlled trial of NHS 
rehabilitation treatment alone verses NHS rehabilitation 
treatment with up to 6 weeks iPAM treatment (up to 30 
sessions) for patients admitted to acute stroke services after 
a new stroke. It was proposed that 90 patients with acute 
stroke were recruited across three NHS stroke units.  
Exlcusion criteria were based on the patient¶s medical 
stability, having no pre-stroke arm movement deficit and 
weight (max 125kg limited by wheelchair). 
In total, 51 patients were recruited to the trial. Twenty-
six patients were recruited to the active group and twenty-
five to the control group. Unfortunately shortly after 
installation of the third iPAM system at Pontefract General 
Infirmary, stroke services within the NHS trust were 
restructured and  early supported discharge introduced. This 
had an effect on recruitment for the trial. After 6 months, 
only three patients had been recruited for the site, one for 
the robot arm and two for the control arm. At this stage it 
was decided that the Pontefract site should be removed from 
the trial.  
Additional issues occurred at Hull Royal Infirmary when 
an outbreak of gastroenteritis resulted in the ward closing. 
During this time a patient recruited to the robot arm of the 
trial was unable to receive any treatment. The therapy gym 
in Aberdeen was also closed for an extended period during 
the trial period due to renovation work; this led to the 
system remaining unused for around four months during the 
two-year trial. 
B. Intervention 
1) Active group: each patient recruited to the iPAM 
group received one to two exercise sessions of iPAM 
delivered therapy per day for up to 30 days on top of usual 
therapy. Each exercise session was approximately 45-60 
minutes or, on occaision, as low as 10 minutes depending on 
WKH SDWLHQW¶V FOLQLFDO VWDWH. iPAM intervention with usual 
NHS rehabilitation treatments was continued for a 
maximum of six weeks. The duration of treatment was less 
if the patient: completes 30 iPAM exercise sessions; no 
longer requires therapy; is discharged from hospital 
(patients were offered the opportunity to come back to 
hospital to complete their course of trial therapy); or there is 
lack of stroke unit staff time to deliver the intervention. The 
decision about need for rehabilitation interventions was 
made by the treating clinicians, therapists and nurses in 
consultation with patients and families as part of the routine 
management of the patient.  
2) Control group: The control group received usual 
therapy plus additional matched therapy time. It was 
estimated from previous patient experience that it takes a 
maximum of 15 minutes to set up the iPAM system and 
prescribe iPAM exercises for each treatment session. 
Therefore on a weekly basis, a maximum of 2.5 hours 
(maximum of two 15 minutes sessions, 5 times per week) 
extra therapy treatment per week was allocated to the 
control group. To be efficient, this extra time therapy was 
often combined or added to usual therapy intervenstion to 
make extra or longer usual therapy sessions. This provided a 
matched burden on therapy resource between the active and 
control group. 
C. Outcomes 
The primary outcome for the RCT was a clinically 
meaningful response (defined as >=3 point improvement in 
Fugl Meyer (Upper limb section) score [13]) from baseline 
to 10 weeks post randomization. Secondary outcome 
measures were: Barthel Index; Stroke Impact Scale; 
ABILHAND; EQ-5D. Results of the clinical outcome 
measures are not included in this paper 
D. Trial discussion 
Over the course of the trial, the iPAM systems undertook 
over 12,500 exercise tasks with no adverse events recorded. 
The Aberdeen system was in use for 1 year, 11 months and 
28 days from the first patient session to the last (including 
the 4 months during which the system went into storage), 
while the Hull system was in use for 1 year, 7 months and 6 
days. While several minor technical issues occurred that 
required a member of the project team to visit the site, the 
safety systems and protocols incorporated into the system 
ensured that none of these resulted in patient harm. As a 
result it was clearly demonstrated that the system could 
operate safely in a clinical environment by suitably trained 
therapy staff. The overall change in Fugl-Meyer Assessment 
± Upper Extremity score across both cohorts was +16.3 
(15.3SD). 
IV. CASE STUDY RESULTS 
During a standard exercise attempt the iPAM system 
records a wealth of data that is stored for later analysis. 
There are several key parameters that can be used to analyse 
the interaction between the robot and patient. A key feature 
of the system as described above is its ability to 
automatically adjust assistance settings based on patient 
achievement. This paper will look at three particular patients 
who exhibited different clinical outcomes and compare these 
outcomes with some parameters measured by the robot 
system. The patient details are presented in Table 1. It should 
be noted that patients during the trial received a varied level 
of both robot and conventional therapist upper-limb 
intervention, with Patient A receiving approximately double 
the intervention as Patient C. 
The patients chosen predominantly used the Category B 
type exercise prescriptions such that as the patient improved, 
achieving more targets during the exercises they would see 
iPAM automatically reducing the assistance level in 5% 
increments.  Each time the assistance level drops, the patient 
must contribute more to the exercise to achieve the same 
number of targets (maximum of eight per exercise attempt). 
In all patients using this strategy we would expect to see 
some early drop off of the assistance level. This is because at 
100% assistance the system will have very high admittance 
parameters, leading to the system behaving in position 
control. In this case iPAM is capable of moving the arm to 
the targets without patient effort. It should be the case that 
after this initial reduction of assistance setting, any changes 
to assistance level would be a result of an improvement in 
patient movement. In a recovering patient we would expect 
to see the assistance level consistently dropping over time 
while the target achievement would drop slightly at each 
reduction of assistance before increasing again to an 
attainment close to 8 targets per exercise. It would be 
envisioned that this continual improvement would continue 
while the patient improved and that by the time assistance 
was down to less than 20%, the patient would require very 
little robot assistance and as such may no longer need iPAM. 
A target is achieved when the hand reaches to within 5cm of 
the virtual target position while a near-miss is set to a 7.5cm 
radius. For this treatment strategy, should a patient 
consistently hit far targets over course of five consecutive 
exercises, the assistance will be lowered by 5%.  
Fig. 3 shows the assistance level for the three patients 
over the course of the treatment sessions. Patient A 
demonstrates a continued improvement as the session 
progress, reducing down to 45% by the end of the treatment. 
Note that assistance often increases to a higher value after an 
initial reduction. SILCK clinic will increase assistance 
should a patient be unable to consistently achieve a near miss 
on far reach targets over 5 consecutive exercises. In the case 
of Patients B and C, it can be seen that there is little 
reduction in assistance overall however it can be seen in this 
case, Patient C actually achieves a lower assistance level 
than patient B, despite a higher FM score at both baseline 
and follow-up. 
Figs. 4, 5 and 6 show the assistance level and target 
achievement against exercise attempt for the three patients, 
A, B and C respectively. To reduce the noise in the target 
achievement data, the line shown is the average value of 
each 10 exercise attempts. A value of 8 would mean every 
target over 10 consecutive exercise attempts was achieved.  
In the case of Patient A (Fig. 4), while assistance level drops 
over the course of the treatment, the rate of target 
achievement stays between 5.8 and 8. This signifies that 
even though the assistance given by the robot is decreasing 
over the course of the treatment, the patient is maintains the 
ability to reach the targets, clearly demonstrating an 
improvement in patient ability as the change in FM score 
would suggest. It can be seen from Fig. 5 that patient B has 
a long period where they are unable to get consistent target 
achievement and during this period no change in assistance 
setting occurs. This last approximately 600 exercises at 
which point the patient begins to achieve a higher level of 
target achievement leading to a reduction in assistance 
which is then temporarily reversed at around 1000 exercises 
before again returning to a lower assistance. It is unclear 
from the clinical notes whether there was any change at the 
patient that led to the change at 800 exercises in.  Patient C 
(Fig. 6) demonstrates a slow decrease in assistance over the 
treatment.  
 
Figure 3.    Assistance level vs exercise attempt for Patients A, B and C. 
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TABLE I.  PATIENT INFORMATION 
Patient Sex Trial Site Affected Side 
Age at 
sign-up 
Type of 
stroke 
Baseline 
Fugl Meyer 
/66 
Follow-up 
Fugl Meyer 
/66 
Change in 
Fugl Meyer 
Standard 
therapy 
(min) 
Robotic 
therapy 
(min) 
A Male Hull Right 38 Infarction 10 48 38 1245 1026 
B Male Aberdeen Left 66 Infarction 23 38 15 620 1079 
C Male Aberdeen Right 48 Infarction 4 4 0 340 741 
 
  
V. CONCLUSION 
This paper presents the iPAM MkII robot system and the 
rationale of a randomised control trial it was used in. A case 
study of three patients was presented demonstrating the 
V\VWHP¶V DELOLW\ WR GHWHFW LPSURYHPHQWV LQ SDWLHQW
performance and adjust assistance level accordingly. A link 
between Fugl-Meyer score and robot assistance levels with 
three patients is discussed each demonstrating a different 
outcome from the trial. This provides therapists with a 
means of undertaking frequent quantitative assessment of 
patient performance and improvement as the treatment 
progresses; a task that is impractical using standard clinical 
measures. 
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Figure 4.    Assistance level and target achievement for Patient A. 
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Figure 5.     Assistance level and target achievement for Patient B. 
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Figure 6.    Assistance level and target achievement for Patient C. 
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